| Revenue growth | FY26 consolidated revenue up 15.2% YoY. |
|---|---|
| Margins | FY26 EBITDA margin at 22.9%; Q4 margin at 23%. |
| Demand visibility | Strong local demand; 61.2% bed occupancy in pre-existing hospitals. |
| Management confidence | High; citing early ahead-of-schedule commissioning of Dombivli facility. |
Growth
FY26 Revenue up 15.2% to ₹1,499.8cr; PAT grew to ₹194.2cr. ARPOB increased 11.7% to ₹67,700.
Outlook
Adding 1,700 beds; targeting 3,000 total capacity. Dombivli ahead of schedule; Pune South on track for 2028.
Risks
Currency depreciation affecting capex costs; inflationary pressures on consumables; execution risks in new multi-city greenfield projects.
Earnings Call filed with BSE, NSE: JLHL. Summary written with AI assistance from the document.
Jupiter Life Line Hospitals Ltd: key numbers
- Share price
- ₹248.55
- Market cap
- ₹8,148 Cr
- Revenue (annual)
- ₹1,500 Cr
- Net profit (annual)
- ₹194.0 Cr
- P/E (TTM)
- 43.4×Sector 53.1×
- Promoter holding
- 40.91%+0.00% QoQ
- FII holding
- 9.37%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jupiter Life Line Hospitals Ltd
All →Jupiter Life Line Hospitals Earnings Call Transcript: Key Takeaways
Management is optimistic as the new Dombivli hospital ramps up, despite it causing a 9.5 crore EBITDA drag this quarter.
Jupiter Life Line Hospitals Other Announcement
Jupiter Life Line Hospitals Limited has authorized specific Key Managerial Personnel for determining and disclosing material events under SEBI Regulation 30(5).
Jupiter Life Line Hospitals Management Change
Jupiter Life Line Hospitals Limited has appointed Mr. Harshad Gaurishankar Purani as the new Chief Financial Officer, effective July 31, 2026.
Jupiter Life Line Hospitals Merger & Restructuring Worth ₹3.78 Cr
Jupiter Life Line Hospitals' subsidiary, Jupiter Hospital Pharmacy, acquired 100% of Sulcus Private Limited for ₹3.78 Crore. This move aims to expand pharmaceutical manufacturing capabilities.
- Value
- ₹3.78 Cr
Jupiter Life Line Hospitals Investor Presentation: Key Takeaways
Jupiter Life Line Hospitals reported Q1FY27 revenue growth of 16.2% YoY, while PAT declined 14.7% due to higher depreciation and finance costs from the new Dombivli facility.
Jupiter Life Line Hospitals Q1 FY27 Results: Net Profit ₹37.5 Cr, Down 14.6% YoY
Jupiter Life Line Hospitals Ltd reported revenue from operations of ₹411 Cr (+16.4% YoY) and net profit of ₹37.5 Cr (-14.6% YoY) for Q1 FY27.
- Key figure
- Net profit ₹37.5 Cr · -14.6% YoY